Search Results

You searched for : lupin  

IPA to host the 11th Global Pharmaceutical Quality Summit February 23-24, 2026, Mumbai

JP Nadda, Hon’ble Union Minister for Health & Family Welfare and Minister of Chemicals and Fertilizers to deliver the keynote address at the inaugural session....
Feb 17

IPA’s 10th Advanced GMP Workshop Calls for Unified Quality Vision to Power India’s USD 450 Billion Pharma Ambition

Reinforcing its commitment to strengthening global manufacturing and quality benchmarks, the Indian Pharmaceutical Alliance (IPA) convened the 10th Advanced Good Manufacturing Practices (GMP) Workshop. The ...
Nov 24

Can India’s Generics Take the Centre Stage and End Weight-Loss Monopoly

Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined....
Aug 11

Top 4 Startups Driving Credit Risk Innovation in India’s Healthcare and Pharma Sector

India’s healthcare and pharmaceutical landscape is undergoing a digital financial shift....
Jun 24

Indian Innovation vs Western Monopolies: Lupin’s FDA Triumph Tells a Bigger Story

Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ...
Jun 03

Lupin Digital Health Introduces Comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology

...
Mar 24

From Dependence to Dominance: Lupin’s Leap in the Diabetes Market

With a focus on affordability, accessibility, and innovation, Lupin is leading the way for better diabetes management and improved quality of life for patients....
Jan 03

9th Edition of the India Health and Wellness Awards 2024 Celebrate Excellence in Healthcare, Innovations in Health and Patient Centric Approach Recognised

The awards ceremony also featured insightful keynote addresses, panel discussions, and networking opportunities, providing attendees with valuable insights and opportunities for collaboration....
Apr 27

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy....
Mar 18

 Transforming Cardiac Care in India: Lupin Digital Health and American College of Cardiology Join Forces

The collaboration between Lupin Digital Health and the American College of Cardiology paves the way for a remarkable advancement in cardiovascular care in India. By ...
Jul 26

Growth of India’s Pharmaceutical Companies

Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had ...
Sep 16

Lupin Launches Tavaborole Topical Solution in the United States

The product will be manufactured at Lupin’s facility in Pithampur, India...
Jul 14

Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets

Sevelamer Hydrochloride Tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis....
Jun 17

Lupin receives UK marketing authorization for Luforbec, first branded generic alternative to Fostair for treatment of Asthma & COPD

...
Jun 14

Lupin Launches Posaconazole Delayed-Release Tablets

Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA...
Feb 17

LupinLife Launches Be One, Ayurvedic Energy Supplement

Be One is a natural, non-addictive and steroid-free daily health supplement for men ...
Feb 10

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ...
Jan 07

Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

Sulfamethoxazole and Trimethoprim Oral Suspension, is indicated for the treatment and prevention of a wide variety of bacterial infections....
Jan 06

Lupin launches Meloxicam Capsules, received approval from USFDA

Meloxicam Capsules indicated for the management of osteoarthritis pain...
Dec 29

Lupin launches Meloxicam Capsules

Meloxicam Capsules is the generic equivalent of Vivlodex Capsules of Zyla Life Sciences US, Inc., and indicated for the management of osteoarthritis (OA) pain....
Dec 28

Lupin receives approval from US FDA for Colesevelam Hydrochloride tablets

Another USFDA approval for Lupin...
Dec 18

Lupin receives approval from USFDA for Penicillamine Tablets USP

Penicillamine Tablets USP, 250 mg, are indicated in the treatment of Wilson’s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis...
Dec 01

Lupin launches Tacrolimus Capsules USP

Tacrolimus Capsules are the generic equivalent of Prograf Capsules of Astellas Pharma US, Inc. and are indicated for the prophylaxis of organ rejection....
Nov 25

Lupin Pharma, announces US FDA has accepted their new drug application for solosec for the treatment of trichomoniasis

If approved for trichomoniasis, Solosec could be the only single-dose oral prescription treatment for both BV and trichomoniasis ...
Nov 16

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Tacrolimus Capsules USP

Tacrolimus Capsules USP are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney or heart transplants...
Nov 12

25 Matching result(s) found!

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026